Occupancy of dopamine D2 and D3 and serotonin 5-HT1A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography

被引：0
|
作者：
Nicholas Seneca
Sjoerd J. Finnema
István Laszlovszky
Béla Kiss
Attila Horváth
Gabriella Pásztor
Margó Kapás
István Gyertyán
Sándor Farkas
Robert B. Innis
Christer Halldin
Balázs Gulyás
机构：
[1] Karolinska Institutet,Department of Clinical Neuroscience, Psychiatry Section
[2] Molecular Imaging Branch,undefined
[3] National Institute of Mental Health,undefined
[4] National Institutes of Health,undefined
[5] Gedeon Richter Ltd.,undefined
来源：
Psychopharmacology | 2011年 / 218卷
关键词：
Cariprazine; Positron emission tomography (PET); Nonhuman primate brain; Dopamine D; Dopamine D; Serotonin 5-HT; Receptor occupancy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：579 / 587
页数：8
相关论文
共 50 条
  • [1] Occupancy of dopamine D2 and D3 and serotonin 5-HT1A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography
    Seneca, Nicholas
    Finnema, Sjoerd J.
    Laszlovszky, Istvan
    Kiss, Bela
    Horvath, Attila
    Pasztor, Gabriella
    Kapas, Margo
    Gyertyan, Istvan
    Farkas, Sandor
    Innis, Robert B.
    Halldin, Christer
    Gulyas, Balazs
    PSYCHOPHARMACOLOGY, 2011, 218 (03) : 579 - 587
  • [2] Discovery of cariprazine (RGH-188): A novel antipsychotic acting on dopamine D3/D2 receptors
    Agai-Csongor, Eva
    Domany, Gyoergy
    Nogradi, Katalin
    Galambos, Janos
    Vago, Istvan
    Keseru, Gyoergy Miklos
    Greiner, Istvan
    Laszlovszky, Istvan
    Gere, Aniko
    Schmidt, Eva
    Kiss, Bela
    Vastag, Monika
    Tihanyi, Karoly
    Saghy, Katalin
    Laszy, Judit
    Gyertyan, Istvan
    Zajer-Balazs, Maria
    Gemesi, Larisza
    Kapas, Margit
    Szombathelyi, Zsolt
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (10) : 3437 - 3440
  • [3] CHARACTERIZATION OF CARIPRAZINE (RGH-188) D3/D2 RECEPTOR OCCUPANCY IN HEALTHY VOLUNTEERS AND SCHIZOPHRENIC PATIENTS BY POSITRON EMISSION TOMOGRAPHY (PET)
    Laszlovszky, I.
    Gage, A.
    Kapas, M.
    Ghahramani, P.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [4] RGH-188, a d3/d2 dopamine receptor antagonist/partial agonist atypical antipsychotic candidate
    Laszlovszky, I.
    Kiss, B.
    Gyertyan, I.
    Meszaros, G. Pasztor
    Seneca, N.
    Schmidt, E.
    Nemethy, Z. S.
    Bugovics, G. Y.
    Saghy, K.
    Laszy, J.
    Kapas, M.
    Nemeth, G. Y.
    Szombathelyi, Z. S.
    EUROPEAN PSYCHIATRY, 2008, 23 : S163 - S163
  • [5] A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
    Girgis, Ragy R.
    Forbes, Andy
    Abi-Dargham, Anissa
    Slifstein, Mark
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (05) : 786 - 792
  • [6] A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
    Ragy R. Girgis
    Andy Forbes
    Anissa Abi-Dargham
    Mark Slifstein
    Neuropsychopharmacology, 2020, 45 : 786 - 792
  • [7] Favourable behavioural actions of RGH-188, a novel dopamine D3/D2 receptor antagonist/partial agonist antipsychotic candidate
    Gyertyan, I.
    Kiss, B.
    Saghy, K.
    Laszy, J.
    Szabo, G.
    Agai-Csongor, E.
    Domany, G.
    Tihanyi, K.
    Szombathelyi, Z.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S12 - S13
  • [8] Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
    Kiss, Bela
    Horvath, Attila
    Nemethy, Zsolt
    Schmidt, Eva
    Laszlovszky, Istvan
    Bugovics, Gyula
    Fazekas, Karoly
    Hornok, Katalin
    Orosz, Szabolcs
    Gyertyan, Istvan
    Agai-Csongor, Eva
    Domany, Gyoergy
    Tihanyi, Karoly
    Adham, Nika
    Szombathelyi, Zsolt
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (01): : 328 - 340
  • [9] Dopamine 1321133 receptor occupancy of RGH-188, a D3/D2 antagonist/partial agonist antipsychotic, in healthy volunteers
    Laszovszky, I.
    Nemeth, G.
    Meszaros, G. Pasztor
    Kapas, M.
    Brooks, D. J.
    Pavese, N.
    Szombathelyi, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S455 - S455
  • [10] RGH-188, a D3/D2 dopamine receptor partial agonist antipsychotic candidate with excellent brain availability and low EPS liability
    Gyertyan, Istvan
    Kiss, Bela
    Saghy, Katalin
    Pasztor, Gabriella
    Gemesi, Larisza I.
    Kapas, Margit
    Agai-Csongor, Eva
    Domany, Gyorgy
    Tihanyi, Karoly
    Szombathelyi, Zsolt
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 76S - 76S
12345